U.S. Physical Therapy (USPH) was Downgraded by Barrington Research to ” Mkt Perform”. Earlier the firm had a rating of “Outperform ” on the company shares. Barrington Research advised their investors in a research report released on Aug 5, 2016.
On the company’s financial health, U.S. Physical Therapy reported $0.57 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.55. The company had revenue of $90.40 million for the quarter, compared to analysts expectations of $90.37 million. The company’s revenue was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.51 EPS.
U.S. Physical Therapy opened for trading at $58.64 and hit $60.99 on the upside on Thursday, eventually ending the session at $60.88, with a gain of 4.16% or 2.43 points. The heightened volatility saw the trading volume jump to 71,004 shares. Company has a market cap of $761 M.
In a different news, on Jun 13, 2016, Lawrance W Mcafee (Chief Financial Officer) sold 2,000 shares at $59.27 per share price. According to the SEC, on May 25, 2016, Bernard A Jr Harris (director) sold 2,912 shares at $19.75 per share price. On May 24, 2016, Regg E. Swanson (director) sold 3,000 shares at $57.29 per share price, according to the Form-4 filing with the securities and exchange commission.
U.S. Physical Therapy Inc. through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders sports-related injuries preventative care rehabilitation of injured workers and neurological-related injuries. The Company primarily operates through subsidiary clinic partnerships in which it owns a 1% general partnership interest and a 64% limited partnership interest and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company provides services at its clinics on an outpatient basis. Patients are treated for approximately one hour per day two to three times a week for two to six weeks. The Company operates approximately 489 clinics in 42 states of the United States.